Silo Pharma, Inc. (SILO): Gross Profit
$27.8K
Year ended 2025-12-31
-$8.0K
Trailing 12 months to 2026-06-30
-25.1%
3-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $27.8K | -58.0% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $66.3K | 0.0% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $66.3K | 0.0% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $66.3K | 0.0% | 2024-03-25, From 2022-01-01 |
| 2021-12-31 | $66.3K | n/m | 2023-03-24, From 2021-01-01 |
| 2020-12-31 | -$135.2K | n/m | 2021-05-17, From 2020-01-01 |
| 2019-12-31 | $13.2K | n/a | 2021-05-17, From 2019-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $27.8K | -58.0% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $10.8K | -98.9% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $21.9K | n/a |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$392.0K | n/a |
| Clene Inc. (CLNN) | 2025-12-31 | $157.0K | -42.3% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $17.6K | n/a |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $20.0K | 0.0% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $12.5K | +210.1% |
| Abvc Biopharma, Inc. (ABVC) | 2024-12-31 | $508.8K | n/m |
Compare SILO, HCWB, BFRG, IBO side by side · Screen every company in Pharmaceutical Preparations ↗